BioSpace News Archive

Scientists Develop 12-Hour Method to Predict Diabetes Onset in Patients Using Artificial Intelligence

Scientists at Klick Applied Sciences have discovered a way to transform a continuous glucose monitor (CGM) into a powerful diabetes screening and prevention tool using artificial intelligence.

December 2, 2022
·
4 min read
Pharm Country

Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)

Ovid Therapeutics Inc. (NASDAQ: OVID) today announced that preclinical data supporting its OV329 and OV350 programs in epilepsy and treatment-resistant seizures will be presented at the 2022 American Epilepsy Society (AES) Annual Meeting, taking place December 2-6 in Nashville, Tennessee.

December 2, 2022
·
6 min read
AIM ImmunoTech Announces Abstract Accepted for Poster Presentation at the British Society for Immunology Congress 2022

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced its abstract has been accepted for poster presentation at the British Society for Immunology Congress 2022 being held December 5-8, 2022 in Liverpool, UK.

December 2, 2022
·
2 min read
Deals

Natus Medical Incorporated to Acquire Micromed Holding SAS

Natus Medical Incorporated has entered into a definitive agreement to acquire Micromed Holding SAS, a global provider of neurophysiology solutions.

December 2, 2022
·
4 min read
Oncolytic Virus Cancer Immunotherapy Market Companies Clinical Trials Insight 2028

Global Oncolytic Virus Immunotherapy Market and Clinical Trials Insight 2028 Report Overview:

December 2, 2022
·
4 min read
Genetown

Rejoni, Inc. Announces First Patients Treated with Juveena™ Hydrogel System in US IDE Pivotal Study

Rejoni, a privately held medical technology company designing and developing hydrogels to improve the standard of care in Women’s Health, announced today that it has begun enrollment of patients in the Juveena Hydrogel System Pivotal Study.

December 2, 2022
·
2 min read
Nuclear Medicine Market Size, Share, Growth, Trends | Report 2022 - 2030

According to Latest Report Study, the global nuclear medicine market size was accounted at USD 8.5 billion in 2021 and is expected to hit around USD 25 billion by 2030, expanding growth at a CAGR 13.2% from 2022 to 2030.

December 2, 2022
·
9 min read
Active Pharmaceutical Ingredients CDMO Market to Touch Valuation of US$ 236.1 Bn by 2030

The global active pharmaceutical ingredients CDMO market size is expected to be worth around US$ 236.1 billion by 2030, according to a new report by Vision Research Reports.

December 2, 2022
·
6 min read
High Potency Active Pharmaceutical Ingredients Market Size, Share, Growth, Trends, Forecast 2021 to 2030

The global high potency active pharmaceutical ingredients market size is expected to be worth around US$ 44.8 billion by 2030, according to a new report by Vision Research Reports.

December 2, 2022
·
8 min read
Pharm Country

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Update: Kaplan Fox Continues to Investigate Potential Securities Fraud

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB) securities.

December 2, 2022
·
2 min read